SAGAR PATEL, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1619382405
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 835 | 25,782 | $13,733,894 | $4,204,198 | $3,322,895 |
| 2023 | 914 | 17,239 | $12,816,812 | $4,028,958 | $3,182,702 |
| 2022 | 922 | 9,490 | $6,521,231 | $3,101,742 | $2,450,669 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 10,500 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 4,500 | $147 | $117 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,400 | $328 | $261 |
| 92134 | Imaging of retina | 1,939 | $41 | $30 |
| J0178 | Injection, aflibercept, 1 mg | 1,458 | $823 | $655 |
| 67028 | Injection of drug into eye | 1,398 | $136 | $103 |
| 92014 | Established patient complete exam of visual system | 1,079 | $127 | $94 |
| J2778 | Injection, ranibizumab, 0.1 mg | 882 | $160 | $127 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 868 | $229 | $182 |
| 92250 | Photography of the retina | 138 | $37 | $29 |
| J3590 | Unclassified biologics | 132 | $2,640 | $2,100 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 116 | $128 | $87 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | S5045 | TX |
| Ophthalmology Physician | 207W00000X | A155024 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.